Geratherm Medical AG (FRA:GME)
Germany
· Delayed Price · Currency is EUR 3.110
-0.020 (-0.64%)
Last updated: May 28, 2025
Geratherm Medical AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 14.38 | 21.6 | 26.42 | 24.41 | 28.12 | Upgrade
|
| Other Revenue | 6.67 | - | - | 0.12 | 0.11 | Upgrade
|
| Revenue | 21.05 | 21.6 | 26.42 | 24.53 | 28.24 | Upgrade
|
| Revenue Growth (YoY) | -2.53% | -18.24% | 7.67% | -13.11% | 38.01% | Upgrade
|
| Cost of Revenue | 8.04 | 5.11 | 10.12 | 8.79 | 10.53 | Upgrade
|
| Gross Profit | 13.01 | 16.49 | 16.29 | 15.74 | 17.71 | Upgrade
|
| Selling, General & Admin | 5.97 | 8.5 | 8.43 | 8.83 | 8.5 | Upgrade
|
| Other Operating Expenses | 3.62 | 4.05 | 4.12 | 4.68 | 4.39 | Upgrade
|
| Operating Expenses | 11.46 | 14.27 | 14.03 | 15.25 | 14.23 | Upgrade
|
| Operating Income | 1.55 | 2.22 | 2.26 | 0.49 | 3.49 | Upgrade
|
| Interest Expense | -0.11 | -0.15 | -0.18 | -0.14 | -0.27 | Upgrade
|
| Interest & Investment Income | - | 0.09 | 0.01 | 0.03 | 0 | Upgrade
|
| Earnings From Equity Investments | - | - | - | -0.03 | -0.05 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.11 | 0.19 | 0.1 | -0.52 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.13 | 0.56 | 0.05 | 0.03 | 0.04 | Upgrade
|
| EBT Excluding Unusual Items | 1.58 | 2.6 | 2.33 | 0.47 | 2.69 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -0 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.61 | -0.53 | -0.75 | -0.21 | -0 | Upgrade
|
| Other Unusual Items | - | 0.22 | 0.11 | 0.03 | 0.02 | Upgrade
|
| Pretax Income | 0.97 | 2.31 | 1.71 | 0.31 | 2.72 | Upgrade
|
| Income Tax Expense | 0.32 | 0.65 | 0.63 | -0.03 | 0.82 | Upgrade
|
| Earnings From Continuing Operations | 0.65 | 1.67 | 1.08 | 0.33 | 1.9 | Upgrade
|
| Minority Interest in Earnings | 0.05 | -0.55 | -0.06 | -0.21 | 0.14 | Upgrade
|
| Net Income | 0.71 | 1.11 | 1.02 | 0.12 | 2.05 | Upgrade
|
| Net Income to Common | 0.71 | 1.11 | 1.02 | 0.12 | 2.05 | Upgrade
|
| Net Income Growth | -36.54% | 8.57% | 737.28% | -94.02% | 274.88% | Upgrade
|
| Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| Shares Change (YoY) | 0.23% | -0.61% | 10.00% | - | - | Upgrade
|
| EPS (Basic) | 0.13 | 0.21 | 0.19 | 0.02 | 0.41 | Upgrade
|
| EPS (Diluted) | 0.13 | 0.21 | 0.19 | 0.02 | 0.41 | Upgrade
|
| EPS Growth | -36.68% | 9.23% | 839.80% | -95.12% | 272.73% | Upgrade
|
| Free Cash Flow | 1.67 | 0.71 | 0.64 | 0.18 | 2.05 | Upgrade
|
| Free Cash Flow Per Share | 0.31 | 0.13 | 0.12 | 0.04 | 0.41 | Upgrade
|
| Dividend Per Share | - | 0.100 | 0.150 | 0.120 | 0.400 | Upgrade
|
| Dividend Growth | - | -33.33% | 25.00% | -70.00% | 60.00% | Upgrade
|
| Gross Margin | 61.80% | 76.36% | 61.68% | 64.16% | 62.72% | Upgrade
|
| Operating Margin | 7.38% | 10.27% | 8.56% | 1.98% | 12.34% | Upgrade
|
| Profit Margin | 3.35% | 5.15% | 3.87% | 0.50% | 7.24% | Upgrade
|
| Free Cash Flow Margin | 7.95% | 3.31% | 2.43% | 0.73% | 7.24% | Upgrade
|
| EBITDA | 3.27 | 3.94 | 3.74 | 1.79 | 4.42 | Upgrade
|
| EBITDA Margin | 15.55% | 18.24% | 14.15% | 7.32% | 15.65% | Upgrade
|
| D&A For EBITDA | 1.72 | 1.72 | 1.48 | 1.31 | 0.93 | Upgrade
|
| EBIT | 1.55 | 2.22 | 2.26 | 0.49 | 3.49 | Upgrade
|
| EBIT Margin | 7.38% | 10.27% | 8.56% | 1.98% | 12.34% | Upgrade
|
| Effective Tax Rate | 32.58% | 27.93% | 36.82% | - | 30.00% | Upgrade
|
| Revenue as Reported | 18.73 | 25.74 | 27.74 | 25.87 | 27.7 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.